Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization

View ORCID ProfileJean-François Rossignol, Matthew C. Bardin, Joshua B. Oaks, B. Gregory Bostick, Kishor N. Vora, Jessica Fulgencio, Dena Mogelnicki, View ORCID ProfileChristian Bréchot, for the Vanguard Study Group
doi: https://doi.org/10.1101/2021.04.19.21255441
Jean-François Rossignol
1Romark Institute of Medical Research, Tampa, Florida
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jean-François Rossignol
Matthew C. Bardin
1Romark Institute of Medical Research, Tampa, Florida
PharmD, BCPS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: matthew.bardin@romark.com
Joshua B. Oaks
2Progressive Clinical Research, Bountiful, Utah
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Gregory Bostick
3Cullman Clinical Trials, Cullman, Alabama
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kishor N. Vora
4Research Integrity, LLC, Owensboro, Kentucky
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Fulgencio
1Romark Institute of Medical Research, Tampa, Florida
MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dena Mogelnicki
1Romark Institute of Medical Research, Tampa, Florida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Bréchot
1Romark Institute of Medical Research, Tampa, Florida
5University of South Florida, College of Medicine, Tampa, Florida
6Global Virus Network
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christian Bréchot
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

Reasonable requests from qualified researchers will be considered for data sharing. These requests should be submitted to medinfo@romark.com.

Back to top
PreviousNext
Posted April 20, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization
Jean-François Rossignol, Matthew C. Bardin, Joshua B. Oaks, B. Gregory Bostick, Kishor N. Vora, Jessica Fulgencio, Dena Mogelnicki, Christian Bréchot, for the Vanguard Study Group
medRxiv 2021.04.19.21255441; doi: https://doi.org/10.1101/2021.04.19.21255441
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization
Jean-François Rossignol, Matthew C. Bardin, Joshua B. Oaks, B. Gregory Bostick, Kishor N. Vora, Jessica Fulgencio, Dena Mogelnicki, Christian Bréchot, for the Vanguard Study Group
medRxiv 2021.04.19.21255441; doi: https://doi.org/10.1101/2021.04.19.21255441

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (139)
  • Cardiovascular Medicine (1947)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (699)
  • Epidemiology (11102)
  • Forensic Medicine (8)
  • Gastroenterology (624)
  • Genetic and Genomic Medicine (3168)
  • Geriatric Medicine (308)
  • Health Economics (561)
  • Health Informatics (2042)
  • Health Policy (863)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12720)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2986)
  • Nursing (164)
  • Nutrition (463)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1552)
  • Ophthalmology (477)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (912)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2785)
  • Public and Global Health (5591)
  • Radiology and Imaging (1094)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (760)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (132)